Free Trial

Laidlaw Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Laidlaw. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Laidlaw.

MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceRating DateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActions
BiomX Inc. stock logo
PHGE
BiomX
$0.36
+5.9%
5/28/2024Initiated byLaidlaw-Buy$2.50N/AView details for Laidlaw rating of BiomX (NYSEMKT:PHGE) on 5/28/2024
IN8bio, Inc. stock logo
INAB
IN8bio
$1.05
+4.0%
3/18/2024Initiated byLaidlaw-Buy$7.50LowView details for Laidlaw rating of IN8bio (NASDAQ:INAB) on 3/18/2024
Alaunos Therapeutics, Inc. stock logo
TCRT
Alaunos Therapeutics
$1.08
-6.1%
8/15/2023Downgraded byLaidlaw-Buy -> HoldLowView details for Laidlaw rating of Alaunos Therapeutics (NASDAQ:TCRT) on 8/15/2023
Vincerx Pharma, Inc. stock logo
VINC
Vincerx Pharma
$0.66
-2.9%
9/13/2021Initiated byLaidlaw-Buy$30.00LowView details for Laidlaw rating of Vincerx Pharma (NASDAQ:VINC) on 9/13/2021
aTyr Pharma, Inc. stock logo
LIFE
aTyr Pharma
$1.79
-0.6%
5/10/2021Initiated byLaidlaw-Buy$18.00HighView details for Laidlaw rating of aTyr Pharma (NASDAQ:LIFE) on 5/10/2021
Affimed stock logo
AFMD
Affimed
$4.20
+0.2%
8/9/2020Reiterated byLaidlaw-Market Perform -> Buy$100.00MediumView details for Laidlaw rating of Affimed (NASDAQ:AFMD) on 8/9/2020
Curis, Inc. stock logo
CRIS
Curis
$11.17
-0.3%
7/29/2020Initiated byLaidlaw-Buy$100.00MediumView details for Laidlaw rating of Curis (NASDAQ:CRIS) on 7/29/2020
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
$40.78
-0.9%
6/5/2020Reiterated byLaidlawAnalyst Yale JenBuy$150.00LowView details for Laidlaw rating of Soleno Therapeutics (NASDAQ:SLNO) on 6/5/2020
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$7.35
-5.5%
6/1/2020Initiated byLaidlaw-Buy$19.00HighView details for Laidlaw rating of Delcath Systems (NASDAQ:DCTH) on 6/1/2020
Aldeyra Therapeutics, Inc stock logo
ALDX
Aldeyra Therapeutics
$3.79
-3.1%
5/26/2020Reiterated byLaidlaw-Buy$30.00LowView details for Laidlaw rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 5/26/2020
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
$40.78
-0.9%
12/23/2019Initiated byLaidlawAnalyst Francois BriseboisBuyHighView details for Laidlaw rating of Soleno Therapeutics (NASDAQ:SLNO) on 12/23/2019
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
$11.13
-0.3%
11/4/2019Initiated byLaidlaw-Buy$500.00HighView details for Laidlaw rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 11/4/2019
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
$15.49
-1.7%
9/24/2019Target Raised byLaidlawAnalyst Francois BriseboisBuy$3.00 -> $6.00LowView details for Laidlaw rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 9/24/2019
Tiziana Life Sciences Ltd stock logo
TLSA
Tiziana Life Sciences
$0.92
+13.6%
9/10/2019Target Set byLaidlawAnalyst Francois BriseboisBuy$20.00N/AView details for Laidlaw rating of Tiziana Life Sciences (NASDAQ:TLSA) on 9/10/2019
Emergent BioSolutions Inc. stock logo
EBS
Emergent BioSolutions
$4.72
-0.8%
9/4/2019Target Set byLaidlawAnalyst Francois BriseboisBuy$72.00LowView details for Laidlaw rating of Emergent BioSolutions (NYSE:EBS) on 9/4/2019
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
$1.39
+3.0%
8/13/2019Downgraded byLaidlaw-Buy -> HoldLowView details for Laidlaw rating of Clearside Biomedical (NASDAQ:CLSD) on 8/13/2019
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
$15.49
-1.7%
8/12/2019Upgraded byLaidlawAnalyst Francois BriseboisHold -> Buy$3.00LowView details for Laidlaw rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 8/12/2019
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
$40.78
-0.9%
7/8/2019Initiated byLaidlaw-Buy$150.00HighView details for Laidlaw rating of Soleno Therapeutics (NASDAQ:SLNO) on 7/8/2019
Affimed stock logo
AFMD
Affimed
$4.20
+0.2%
7/3/2019Target Set byLaidlawAnalyst Yale JenBuy$100.00LowView details for Laidlaw rating of Affimed (NASDAQ:AFMD) on 7/3/2019
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
$0.67
5/29/2019Target Raised byLaidlawAnalyst James MolloyBuy$26.00 -> $32.00LowView details for Laidlaw rating of Cara Therapeutics (NASDAQ:CARA) on 5/29/2019
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
$15.49
-1.7%
3/18/2019Target Set byLaidlawAnalyst Francois BriseboisHold$2.00MediumView details for Laidlaw rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 3/18/2019
BioSig Technologies, Inc. stock logo
BSGM
BioSig Technologies
$2.06
+19.1%
2/20/2019Target Set byLaidlawAnalyst Francois BriseboisBuy$110.00MediumView details for Laidlaw rating of BioSig Technologies (NASDAQ:BSGM) on 2/20/2019
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
$38.41
+26.3%
2/19/2019Initiated byLaidlaw-BuyLowView details for Laidlaw rating of Arcturus Therapeutics (NASDAQ:ARCT) on 2/19/2019
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
$0.67
12/20/2018Target Set byLaidlawAnalyst James MolloyBuy$30.00LowView details for Laidlaw rating of Cara Therapeutics (NASDAQ:CARA) on 12/20/2018
Tiziana Life Sciences Ltd stock logo
TLSA
Tiziana Life Sciences
$0.92
+13.6%
12/17/2018Initiated byLaidlaw-Buy -> BuyHighView details for Laidlaw rating of Tiziana Life Sciences (NASDAQ:TLSA) on 12/17/2018
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
$1.39
+3.0%
11/6/2018Target Set byLaidlawAnalyst Francois BriseboisBuy$5.00LowView details for Laidlaw rating of Clearside Biomedical (NASDAQ:CLSD) on 11/6/2018
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
$15.49
-1.7%
11/6/2018Downgraded byLaidlaw-Buy -> Hold$6.00HighView details for Laidlaw rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 11/6/2018
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
$1.39
+3.0%
7/16/2018Initiated byLaidlaw-Buy$18.00HighView details for Laidlaw rating of Clearside Biomedical (NASDAQ:CLSD) on 7/16/2018
Viking Therapeutics, Inc. stock logo
VKTX
Viking Therapeutics
$65.36
+4.2%
6/1/2018Target Raised byLaidlaw-Buy$10.00 -> $15.00HighView details for Laidlaw rating of Viking Therapeutics (NASDAQ:VKTX) on 6/1/2018
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
$0.67
5/24/2018Target Set byLaidlawAnalyst Francois BriseboisBuy$26.00LowView details for Laidlaw rating of Cara Therapeutics (NASDAQ:CARA) on 5/24/2018
MEI Pharma, Inc. stock logo
MEIP
MEI Pharma
$3.08
-0.6%
4/12/2018Initiated byLaidlaw-Buy$140.00HighView details for Laidlaw rating of MEI Pharma (NASDAQ:MEIP) on 4/12/2018
Marinus Pharmaceuticals, Inc. stock logo
MRNS
Marinus Pharmaceuticals
$1.50
+8.7%
12/14/2017Initiated byLaidlaw-Buy -> Buy$72.00HighView details for Laidlaw rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 12/14/2017
Fennec Pharmaceuticals Inc. stock logo
FRX
Fennec Pharmaceuticals
C$9.41
+2.7%
11/29/2017Initiated byLaidlaw-BuyC$22.00N/AView details for Laidlaw rating of Fennec Pharmaceuticals (TSE:FRX) on 11/29/2017
Fennec Pharmaceuticals Inc stock logo
FENC
Fennec Pharmaceuticals
$7.03
+4.9%
11/29/2017Initiated byLaidlaw-Buy -> Buy$22.00HighView details for Laidlaw rating of Fennec Pharmaceuticals (NASDAQ:FENC) on 11/29/2017
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
$11.13
-0.3%
11/8/2017Initiated byLaidlaw-Buy$500.00N/AView details for Laidlaw rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 11/8/2017
DURECT Co. stock logo
DRRX
DURECT
$1.24
-4.6%
10/20/2017Target Lowered byLaidlaw-Buy -> Buy$30.00 -> $20.00N/AView details for Laidlaw rating of DURECT (NASDAQ:DRRX) on 10/20/2017
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
$37.64
+1.0%
8/14/2017Reiterated byLaidlaw-Buy$65.00LowView details for Laidlaw rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 8/14/2017
iCAD, Inc. stock logo
ICAD
iCAD
$1.53
-3.2%
7/25/2017Reiterated byLaidlaw-Buy$11.00MediumView details for Laidlaw rating of iCAD (NASDAQ:ICAD) on 7/25/2017
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
$0.67
6/30/2017Target Lowered byLaidlaw-Buy$35.00 -> $30.00HighView details for Laidlaw rating of Cara Therapeutics (NASDAQ:CARA) on 6/30/2017
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
$0.67
3/28/2017Reiterated byLaidlaw-Buy -> Buy$20.00 -> $35.00HighView details for Laidlaw rating of Cara Therapeutics (NASDAQ:CARA) on 3/28/2017
You won't believe what Citigroup just did to it's depositors (Ad)

The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...

CLICK HERE TO GET YOUR GUIDE NOW
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
$0.67
3/10/2017Target Raised byLaidlaw-Buy -> Buy$17.00 -> $20.00MediumView details for Laidlaw rating of Cara Therapeutics (NASDAQ:CARA) on 3/10/2017
OPKO Health, Inc. stock logo
OPK
OPKO Health
$1.36
1/3/2017Reiterated byLaidlaw-Buy$22.00 -> $19.00N/AView details for Laidlaw rating of OPKO Health (NASDAQ:OPK) on 1/3/2017
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
$37.64
+1.0%
12/27/2016Target Raised byLaidlaw-Buy$59.00 -> $65.00N/AView details for Laidlaw rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 12/27/2016
Axon Enterprise, Inc. stock logo
AXON
Axon Enterprise
$288.20
+0.9%
12/20/2016Initiated byLaidlaw-Sell$7.50N/AView details for Laidlaw rating of Axon Enterprise (NASDAQ:AXON) on 12/20/2016
VBI Vaccines Inc. stock logo
VBIV
VBI Vaccines
$0.64
-1.5%
10/10/2016Initiated byLaidlaw-Buy$120.00N/AView details for Laidlaw rating of VBI Vaccines (NASDAQ:VBIV) on 10/10/2016
Viking Therapeutics, Inc. stock logo
VKTX
Viking Therapeutics
$65.36
+4.2%
8/11/2016Target Lowered byLaidlaw-Buy$20.00 -> $10.00N/AView details for Laidlaw rating of Viking Therapeutics (NASDAQ:VKTX) on 8/11/2016
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
$0.67
2/29/2016Target Lowered byLaidlaw-Buy$30.00 -> $17.00N/AView details for Laidlaw rating of Cara Therapeutics (NASDAQ:CARA) on 2/29/2016
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
$15.49
-1.7%
1/21/2016Target Lowered byLaidlaw-Buy$30.00 -> $25.00N/AView details for Laidlaw rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 1/21/2016
Affimed stock logo
AFMD
Affimed
$4.20
+0.2%
12/10/2015Initiated byLaidlaw-Buy$150.00N/AView details for Laidlaw rating of Affimed (NASDAQ:AFMD) on 12/10/2015
OPKO Health, Inc. stock logo
OPK
OPKO Health
$1.36
8/13/2015Initiated byLaidlaw-Buy$22.00N/AView details for Laidlaw rating of OPKO Health (NASDAQ:OPK) on 8/13/2015
OPKO Health, Inc. stock logo
OPK
OPKO Health
$1.36
8/12/2015Initiated byLaidlaw-Buy$22.00N/AView details for Laidlaw rating of OPKO Health (NASDAQ:OPK) on 8/12/2015
Aldeyra Therapeutics, Inc stock logo
ALDX
Aldeyra Therapeutics
$3.79
-3.1%
1/26/2015Initiated byLaidlawAnalyst Yale JenBuy$30.00N/AView details for Laidlaw rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 1/26/2015
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
$37.64
+1.0%
12/9/2014Target Raised byLaidlaw-$65.00N/AView details for Laidlaw rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 12/9/2014
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
$37.64
+1.0%
11/25/2014Reiterated byLaidlaw-BuyN/AView details for Laidlaw rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 11/25/2014
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
$37.64
+1.0%
8/12/2014Initiated byLaidlaw-Buy$52.00N/AView details for Laidlaw rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 8/12/2014
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
$9.70
-3.1%
6/30/2014Initiated byLaidlaw-BuyN/AView details for Laidlaw rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 6/30/2014
Stratasys Ltd. stock logo
SSYS
Stratasys
$9.14
+0.9%
3/7/2014Initiated byLaidlaw-Buy$145.00N/AView details for Laidlaw rating of Stratasys (NASDAQ:SSYS) on 3/7/2014
Omnicell, Inc. stock logo
OMCL
Omnicell
$32.40
-0.7%
3/5/2014Target Raised byLaidlaw-Buy$29.00 -> $34.00N/AView details for Laidlaw rating of Omnicell (NASDAQ:OMCL) on 3/5/2014
Surmodics, Inc. stock logo
SRDX
Surmodics
$35.10
+2.1%
2/25/2014Initiated byLaidlaw-Buy$30.00N/AView details for Laidlaw rating of Surmodics (NASDAQ:SRDX) on 2/25/2014
Omnicell, Inc. stock logo
OMCL
Omnicell
$32.40
-0.7%
1/28/2014Target Raised byLaidlaw-Buy$27.00 -> $29.00N/AView details for Laidlaw rating of Omnicell (NASDAQ:OMCL) on 1/28/2014

MarketBeat Community Rating for Laidlaw

Community Ranking:  2.7 out of 5 (
2.7 of 5 stars)
Outperform Votes:  25,764 (Vote Outperform)
Underperform Votes:  22,477 (Vote Underperform)
Total Votes:  48,241
MarketBeat's community ratings are surveys of what our community members think about Laidlaw and other research firms. Vote "Outperform" if you believe Laidlaw's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Laidlaw's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Forecasts and Research Tools